TRANSGENE risk profile

65 Stretched several inputs deteriorating together

Measured 21 October 2026 from TNG.PA's filed statements. Recomputed nightly.

65 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation76StretchedVolatileDrawdown from the 52-week high — 53.4%
Operating pressure36NormalEasingOperating-margin drift — -6,080.9 percentage points
Cash conversion100AcuteStableCapital spending against operating cash — -0.02x
Leverage and coverage35NormalEasingInterest cover — -26.65x
Competitive position80AcuteStableOperating-margin gap against peers — -6,935.0 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for TRANSGENE